There are many prognostic variables in multiple myeloma and the difficulty is in deciding which is truly significant. The widely used International Staging System (ISS) does not incorporate genetics, age, and other important variables in its risk stratification. Although it has its own limitations, the recently published Revised International Staging System (R-ISS) that was built upon the framework of ISS, is a more comprehensive and predictive tool for multiple myeloma patients and should be henceforth utilised. We will review the current prognostic variables and their significance in this paper.
CITATION STYLE
Ooi, M. G. M., de Mel, S., & Chng, W. J. (2016, April 1). Risk Stratification in Multiple Myeloma. Current Hematologic Malignancy Reports. Current Science Inc. https://doi.org/10.1007/s11899-016-0307-4
Mendeley helps you to discover research relevant for your work.